NSE · SUVEN
Suven Life Sciences Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#639
of 5,004 stocks
▼ 191W
Peak #620 · 21 Sep 2026
Operating in Healthcare, Suven Life Sciences Limited has a subdued return on equity, remains firmly promoter-controlled, with promoters holding 65%, and is growing revenue modestly.
Market Cap
8,453.06 Cr
P/E Ratio
—
P/B Ratio
14.28
ROE
-46.73%
ROCE
-46.55%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 3.57 Cr | 1.52 Cr | 2.81 Cr | 91.92 L |
| Net Profit | -127.61 Cr | -45.60 Cr | -101.92 Cr | -77.31 Cr |
| EPS | -4.84 | -2.02 | -4.55 | -3.48 |
| Operating Profit | -127.13 Cr | -45.44 Cr | -101.92 Cr | -77.31 Cr |
Shareholding pattern
Promoter
65.47%
Public
34.53%
Mutual fund holdings
₹0.10
Cr total
3
Schemes
2
Fund Houses
₹0.10 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.07 Cr (67.3%)
Bandhan Mutual Fund₹0.03 Cr (32.7%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 30 Jul 2024 | Other | Annual General Meeting |
| 02 Aug 2023 | Other | Annual General Meeting |
| 17 Oct 2022 | Rights | Rights 1:2 @ Premium Rs 54/- |
| 29 Jul 2022 | Other | Annual General Meeting |
| 02 Aug 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.